David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Employers Holdings
EIG
$883M
| $4.54M | ﹤0.01% |
96,153
+19,716
| +26% | +$951K |
|
|
TVA
2002
Texas Ventures Acquisition III Corp
TVA
$316M
| $4.54M | ﹤0.01% |
+450,000
| New | +$4.52M |
|
2003
Banco Bradesco
BBD
$35.5B
| $4.53M | ﹤0.01% |
1,467,030
-18,844,229
| -93% | -$49.6M |
|
2004
Medifast
MED
$137M
| $4.51M | ﹤0.01% |
321,229
-12,217
| -4% | -$161K |
|
2005
First Internet Bancorp
INBK
$239M
| $4.5M | ﹤0.01% |
167,357
+40,184
| +32% | +$958K |
|
2006
Ameris Bancorp
ABCB
$5.76B
| $4.49M | ﹤0.01% |
69,470
-43,732
| -39% | -$2.59M |
|
|
OPFI.WS
2007
DELISTED
OppFi Inc Warrants
OPFI.WS
| $4.49M | ﹤0.01% |
1,049,673
| – | – |
|
2008
PUT
TFI International
TFII
$11.1B
| $4.49M | ﹤0.01% |
50,000
| – | – |
|
2009
CALL
Ares Capital
ARCC
$14.3B
| $4.49M | ﹤0.01% |
204,300
+184,400
| +927% | +$3.92M |
|
2010
BrightView Holdings
BV
$1.02B
| $4.47M | ﹤0.01% |
268,254
+15,953
| +6% | +$239K |
|
|
KREF
2011
KKR Real Estate Finance Trust
KREF
$485M
| $4.46M | ﹤0.01% |
508,960
+103,853
| +26% | +$956K |
|
2012
EnerSys
ENS
$6.96B
| $4.46M | ﹤0.01% |
51,991
-140,474
| -73% | -$12.2M |
|
2013
CALL
AstraZeneca
AZN
$258B
| $4.46M | ﹤0.01% |
31,900
+30,450
| +2,100% | +$4.27M |
|
2014
ANI Pharmaceuticals
ANIP
$1.71B
| $4.46M | ﹤0.01% |
68,292
-161,409
| -70% | -$10.5M |
|
2015
BWX Technologies
BWXT
$14B
| $4.45M | ﹤0.01% |
30,867
-73,275
| -70% | -$8.56M |
|
2016
Xenon Pharmaceuticals
XENE
$6.18B
| $4.44M | ﹤0.01% |
141,783
-10,405
| -7% | -$339K |
|
2017
PubMatic
PUBM
$740M
| $4.43M | ﹤0.01% |
356,381
-95,529
| -21% | -$1.01M |
|
2018
PUT
Nutanix
NTNX
$17.7B
| $4.42M | ﹤0.01% |
57,800
+14,700
| +34% | +$1.06M |
|
2019
Douglas Elliman
DOUG
$171M
| $4.4M | ﹤0.01% |
1,895,396
+252,039
| +15% | +$538K |
|
2020
ProPetro Holding
PUMP
$1.31B
| $4.38M | ﹤0.01% |
733,249
+244,745
| +50% | +$1.4M |
|
2021
White Mountains Insurance
WTM
$5.09B
| $4.37M | ﹤0.01% |
2,436
+78
| +3% | +$139K |
|
2022
Main Street Capital
MAIN
$5.46B
| $4.37M | ﹤0.01% |
73,957
+65,643
| +790% | +$3.63M |
|
|
TGB
2023
Trekor Metals
TGB
$3.38B
| $4.37M | ﹤0.01% |
1,387,211
-372,790
| -21% | -$872K |
|
2024
RH
RH
$2.81B
| $4.37M | ﹤0.01% |
+23,104
| New | +$4.29M |
|
2025
PUT
IBM
IBM
$217B
| $4.36M | ﹤0.01% |
14,800
-136,900
| -90% | -$35.3M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.